NEFL and Alzheimer disease: The Gothenburg cohort results show, in a simple comparison between participants with AD and cognitively healthy individuals, the low abundance of AINX in CSF, and the similarities to NfL when it comes to biomarker performance, the latter having been proven multiple times to be a marker for general neurodegeneration [32–34].